RxDoctor Payments Data

Noelle Windsor, DO

Family Medicine · Ventura, CANPI 1306331129

Payments from drug & device makers

$2,109in general payments, 2019–2025

Across 52 payments — averaging $40.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$1K
  • Gilead$163
  • Nevro Corp.$156
  • Silk Road Medical, Inc.$150
  • AbbVie$123
  • Stryker$120
  • plus $368 from 10 others

What the payments were for

  • Food & beverage$2,109100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,109 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$99,159
Medicare patients
166
Services billed
1,476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide13$14,295
SantylCollagenase Clostridium Hist.11$4,529
Gabapentin26$496
Gentamicin Sulfate11$375
Doxycycline Hyclate17$304
Levocetirizine Dihydrochloride18$298
Levothyroxine Sodium28$296
Escitalopram Oxalate20$258
Atorvastatin Calcium47$224
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen15$214
Mupirocin28$210
Omeprazole12$199
Pantoprazole Sodium16$183
Metformin Hcl11$159
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$122

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$1,030$4,52911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,533 family medicine providers in California.

Other family medicine in Ventura

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →